Stock Analiz

Design Therapeutics, Inc. (DSGN) stock forecast and price target

Price $10.47 · data as of November 13, 2026

12-month price target

Average target$21.57
Upside / downside+106.0%
Analysts7
ConsensusStrong buy
Low $19.00Average $21.57High $26.00

Gold marker: average target · white marker: today’s price ($10.47)

Analyst ratings

Strong buy 2Buy 6Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.34−9.8%$0
Next fiscal year
ends December 31, 2027
$-1.55−16.0%$0
Next quarter
ends December 31, 2026
$-0.40−46.3%$0
Quarter after
ends March 31, 2027
$-0.35−22.1%$0

Consensus of the analysts covering Design Therapeutics, updated daily. In the last 30 days 4 estimates were raised and 0 lowered.

Frequently asked questions

What is the Design Therapeutics stock price target?

The average 12-month target from 7 analysts is $21.57, 106.0% above the current price of $10.47 Targets range from $19.00 to $26.00.

Is Design Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 6 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Design Therapeutics expected to earn?

Analysts expect EPS of $-1.34 for the fiscal year ending December 31, 2026 and $-1.55 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.